La Trobe

Influence of species and processing parameters on recovery and content of brain tissue-derived extracellular vesicles

journal contribution
posted on 2025-10-24, 03:44 authored by Yiyao Huang, Lesley SimLesley Sim, A Turchinovich, V Mahairaki, JC Troncoso, O Pletniková, NJ Haughey, LJ Vella, Andrew HillAndrew Hill, L Zheng, KW Witwer
Extracellular vesicles (EVs) are involved in a wide range of physiological and pathological processes by shuttling material out of and between cells. Tissue EVs may thus lend insights into disease mechanisms and also betray disease when released into easily accessed biological fluids. Since brain-derived EVs (bdEVs) and their cargo may serve as biomarkers of neurodegenerative diseases, we evaluated modifications to a published, rigorous protocol for separation of EVs from brain tissue and studied effects of processing variables on quantitative and qualitative outcomes. To this end, size exclusion chromatography (SEC) and sucrose density gradient ultracentrifugation were compared as final separation steps in protocols involving stepped ultracentrifugation. bdEVs were separated from brain tissues of human, macaque, and mouse. Effects of tissue perfusion and a model of post-mortem interval (PMI) before final bdEV separation were probed. MISEV2018-compliant EV characterization was performed, and both small RNA and protein profiling were done. We conclude that the modified, SEC-employing protocol achieves EV separation efficiency roughly similar to a protocol using gradient density ultracentrifugation, while decreasing operator time and, potentially, variability. The protocol appears to yield bdEVs of higher purity for human tissues compared with those of macaque and, especially, mouse, suggesting opportunities for optimization. Where possible, perfusion should be performed in animal models. The interval between death/tissue storage/processing and final bdEV separation can also affect bdEV populations and composition and should thus be recorded for rigorous reporting. Finally, different populations of EVs obtained through the modified method reported herein display characteristic RNA and protein content that hint at biomarker potential. To conclude, this study finds that the automatable and increasingly employed technique of SEC can be applied to tissue EV separation, and also reveals more about the importance of species-specific and technical considerations when working with tissue EVs. These results are expected to enhance the use of bdEVs in revealing and understanding brain disease.<p></p>

Funding

This work was supported by the Michael J. Fox Foundation for Parkinson's Research; NIH Office of the Director [CA241694]; National Institute of Allergy and Infectious Diseases [AI144997]; National Institute of Mental Health [MH118164]; National Institute on Aging [AG057430]; National Institute on Drug Abuse [DA040385]; National Institute on Drug Abuse [DA047807]; National Health and Medical Research Council of Australia [GNT1132604].

History

Publication Date

2020-09-01

Journal

Journal of Extracellular Vesicles

Volume

9

Issue

1

Article Number

1785746

Pagination

20p.

Publisher

Taylor & Francis

ISSN

2001-3078

Rights Statement

© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of The International Society for Extracellular Vesicles. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Usage metrics

    Journal Articles

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC